Wikidata

(Q57569586)

English

LBA3_PRA PHASE 3 RANDOMIZED, OPEN-LABEL STUDY OF NIVOLUMAB (ANTI-PD-1; BMS-936558; ONO-4538) VERSUS INVESTIGATOR'S CHOICE CHEMOTHERAPY (ICC) IN PATIENTS WITH ADVANCED MELANOMA AFTER PRIOR ANTI-CTLA-4 THERAPY

No description defined

In more languages

Statements

title
LBA3_PRA PHASE 3 RANDOMIZED, OPEN-LABEL STUDY OF NIVOLUMAB (ANTI-PD-1; BMS-936558; ONO-4538) VERSUS INVESTIGATOR'S CHOICE CHEMOTHERAPY (ICC) IN PATIENTS WITH ADVANCED MELANOMA AFTER PRIOR ANTI-CTLA-4 THERAPY (English)
0 references
author
Paul Lorigan
object named as
P. Lorigan
series ordinal
15
0 references
Sandra P D'Angelo
series ordinal
3
object named as
S.P. D'Angelo
0 references
author name string
J.S. Weber
series ordinal
1
0 references
D.R. Minor
series ordinal
2
0 references
F.S. Hodi
series ordinal
4
0 references
R. Gutzmer
series ordinal
5
0 references
B. Neyns
series ordinal
6
0 references
C. Hoeller
series ordinal
7
0 references
N.I. Khushalani
series ordinal
8
0 references
W.H. Miller
series ordinal
9
0 references
J-J. Grob
series ordinal
10
0 references
C. Lao
series ordinal
11
0 references
G. Linette
series ordinal
12
0 references
K. Grossmann
series ordinal
13
0 references
J.C. Hassel
series ordinal
14
0 references
M. Maio
series ordinal
16
0 references
M. Sznol
series ordinal
17
0 references
A. Lambert
series ordinal
18
0 references
A. Yang
series ordinal
19
0 references
J. Larkin
series ordinal
20
0 references
publication date
September 2014
0 references
volume
25
0 references
issue
suppl_4
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q57569586&oldid=2033423318"